Albuterol Sulfate Solution
Product Images NDC 50742-393

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 50742-393). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.63pouch (993b7d8f 7aaf 4c39 87c5 B3437c718e07 08)

0.63pouch (993b7d8f 7aaf 4c39 87c5 B3437c718e07 08)
Label of Albuterol Sulfate Inhalation Solution 0.63 mg per 3 mL by Ingenus Pharmaceuticals, LLC. The label indicates it contains sterile unit-dose vials with five 3 mL vials per pouch, for inhalation only. It includes storage conditions, usage instructions, and a barcode.*
FDA Label Image

1.25pouch (993b7d8f 7aaf 4c39 87c5 B3437c718e07 09)

1.25pouch (993b7d8f 7aaf 4c39 87c5 B3437c718e07 09)
The label for Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL by Ingenus Pharmaceuticals, LLC. It states the product is a sterile unit-dose vial for respiratory inhalation use only. The pouch contains five 3 mL vials. Additional details include storage instructions, active and inactive ingredients, and usage directions.*
FDA Label Image

0.63carton (993b7d8f 7aaf 4c39 87c5 B3437c718e07 10)

0.63carton (993b7d8f 7aaf 4c39 87c5 B3437c718e07 10)
Packaging label for Albuterol Sulfate Inhalation Solution, 0.63 mg per 3 mL, from Ingenus Pharmaceuticals, LLC. The label states it is a sterile unit-dose vial for inhalation use only, with each unit dose containing 0.63 mg of albuterol sulfate equivalent to 0.75 mg of albuterol base. The product is distributed in cartons containing 25 vials. The label includes ingredient, storage, dosage, and manufacturer information along with the NDC 50742-392-25.*
FDA Label Image

1.25carton (993b7d8f 7aaf 4c39 87c5 B3437c718e07 11)

1.25carton (993b7d8f 7aaf 4c39 87c5 B3437c718e07 11)
Packaging label for Albuterol Sulfate Inhalation Solution, 1.25 mg per 3 mL, by Ingenus Pharmaceuticals, LLC. The label indicates sterile unit-dose vials intended for inhalation use only. It includes the NDC 50742-393-25 and states that each unit dose contains 1.25 mg of albuterol equivalent to 1.5 mg of albuterol sulfate. The carton holds 25 vials in 5 pouches of 5 x 3 mL units each. Additional information includes storage instructions and a note to detach patient instructions before dispensing.*
FDA Label Image

Structure (B1c8426f 0f23 41b1 A251 2499e1379bff 01)

Structure (B1c8426f 0f23 41b1 A251 2499e1379bff 01)
Chemical structure diagram of Albuterol Sulfate showing the molecular arrangement with hydroxyl groups and sulfate moiety, labeled as a dimer. This structure corresponds to the active ingredient Albuterol Sulfate.*
FDA Label Image

Image1 (B1c8426f 0f23 41b1 A251 2499e1379bff 02)

Image1 (B1c8426f 0f23 41b1 A251 2499e1379bff 02)
A line graph showing percentage change over time in hours from pre-dose for Albuterol Sulfate solutions and placebo. Three treatments are plotted: albuterol 1.25 mg, albuterol 0.63 mg, and placebo, with percentage change on the y-axis and hours from pre-dose on the x-axis. The graph illustrates trends in response over six hours for each treatment group.*
FDA Label Image

Image2 (B1c8426f 0f23 41b1 A251 2499e1379bff 03)

Image2 (B1c8426f 0f23 41b1 A251 2499e1379bff 03)
A line graph plotting percentage change against hours from pre-dose, displaying treatment effects of Albuterol Sulfate solution at 1.25 mg and 0.63 mg doses compared to placebo. The graph shows percentage change on the y-axis (0 to 30%) and time on the x-axis (0 to 6 hours), with separate lines for each treatment indicating the variations over time.*
FDA Label Image

Image (B1c8426f 0f23 41b1 A251 2499e1379bff 33 2)

Image (B1c8426f 0f23 41b1 A251 2499e1379bff 33 2)
An instructional diagram showing use of a dropper bottle to place liquid into a measuring device with a mouthpiece, likely demonstrating preparation or administration of a respiratory inhalation solution.*
FDA Label Image

Image (B1c8426f 0f23 41b1 A251 2499e1379bff 33 3)

Image (B1c8426f 0f23 41b1 A251 2499e1379bff 33 3)
An instructional diagram showing the connection of an inhalation solution nebulizer mouthpiece or mask to the nebulizer machine. The image depicts the mouthpiece and the tubing or connector that attaches to the nebulizer device for respiratory administration.*
FDA Label Image

Image (B1c8426f 0f23 41b1 A251 2499e1379bff 33 4)

Image (B1c8426f 0f23 41b1 A251 2499e1379bff 33 4)
Illustrations showing two methods of inhalation using a device for Albuterol Sulfate solution. The first image depicts a user inhaling directly from a mouthpiece, while the second image shows inhalation using a spacer device attached to the mouthpiece for respiratory administration.*
FDA Label Image

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.